TLS mutation - PubMed (original) (raw)

FUS/TLS-immunoreactive neuronal and glial cell inclusions increase with disease duration in familial amyotrophic lateral sclerosis with an R521C FUS/TLS mutation

Naoki Suzuki et al. J Neuropathol Exp Neurol. 2012 Sep.

Erratum in

J Neuropathol Exp Neurol. 2015 Sep;74(9):945

Abstract

Basophilic inclusions (BIs) are pathological features of a subset of frontotemporal lobar degeneration disorders, including sporadic amyotrophic lateral sclerosis (ALS) and familial ALS (FALS). Mutations in the fused in sarcoma/translocated in liposarcoma (FUS/TLS) gene have recently been identified as a cause of FALS. The FUS/TLS-immunoreactive inclusions are consistently found in cases of frontotemporal lobar degeneration with BIs; however, the association between ALS cases with BIs and FUS/TLS accumulation is not well understood. We used immunohistochemistry to analyze 3 autopsy cases of FALS with the FUS/TLS mutation and with BIs using anti-FUS/TLS antibodies. The disease durations were 1, 3, and 9 years. As the disease duration becomes longer, there were broader distributions of neuronal and glial FUS/TLS-immunoreactive inclusions. As early as 1 year after the onset, BIs, neuronal cytoplasmic inclusions and glial cytoplasmic inclusions were found in the substantia nigra in addition to the anterior horn of the spinal cord. Glial cytoplasmic inclusions are found earlier and in a wider distribution than neuronal cytoplasmic inclusions. The distribution of FUS/TLS-immunoreactive inclusions in FUS/TLS-mutated FALS with BIs was broader than that of BIs alone, suggesting that the pathogenetic mechanism may have originated from the FUS/TLS proteinopathy.

PubMed Disclaimer

Cited by

Synaptic dysfunction in ALS and FTD: anatomical and molecular changes provide insights into mechanisms of disease.
Gelon PA, Dutchak PA, Sephton CF. Gelon PA, et al. Front Mol Neurosci. 2022 Oct 3;15:1000183. doi: 10.3389/fnmol.2022.1000183. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36263379 Free PMC article. Review.
Missing in Action: Dysfunctional RNA Metabolism in Oligodendroglial Cells as a Contributor to Neurodegenerative Diseases?
Hoch-Kraft P, Trotter J, Gonsior C. Hoch-Kraft P, et al. Neurochem Res. 2020 Mar;45(3):566-579. doi: 10.1007/s11064-019-02763-y. Epub 2019 Mar 6. Neurochem Res. 2020. PMID: 30843138 Review.
The role of FUS gene variants in neurodegenerative diseases.
Deng H, Gao K, Jankovic J. Deng H, et al. Nat Rev Neurol. 2014 Jun;10(6):337-48. doi: 10.1038/nrneurol.2014.78. Epub 2014 May 20. Nat Rev Neurol. 2014. PMID: 24840975 Review.
Establishment of In Vitro FUS-Associated Familial Amyotrophic Lateral Sclerosis Model Using Human Induced Pluripotent Stem Cells.
Ichiyanagi N, Fujimori K, Yano M, Ishihara-Fujisaki C, Sone T, Akiyama T, Okada Y, Akamatsu W, Matsumoto T, Ishikawa M, Nishimoto Y, Ishihara Y, Sakuma T, Yamamoto T, Tsuiji H, Suzuki N, Warita H, Aoki M, Okano H. Ichiyanagi N, et al. Stem Cell Reports. 2016 Apr 12;6(4):496-510. doi: 10.1016/j.stemcr.2016.02.011. Epub 2016 Mar 17. Stem Cell Reports. 2016. PMID: 26997647 Free PMC article.
Neuronal dysfunction caused by FUSR521G promotes ALS-associated phenotypes that are attenuated by NF-κB inhibition.
Pelaez MC, Desmeules A, Gelon PA, Glasson B, Marcadet L, Rodgers A, Phaneuf D, Pozzi S, Dutchak PA, Julien JP, Sephton CF. Pelaez MC, et al. Acta Neuropathol Commun. 2023 Nov 16;11(1):182. doi: 10.1186/s40478-023-01671-1. Acta Neuropathol Commun. 2023. PMID: 37974279 Free PMC article.

FUS/TLS-immunoreactive neuronal and glial cell inclusions increase with disease duration in familial amyotrophic lateral sclerosis with an R521C FUS/TLS mutation - PubMed (original) (raw)